What To Expect From Rite Aid’s Earnings
Rite Aid Corporation (NYSE:RAD) is scheduled to announce its fiscal fourth quarter and full year results on April 25 before the markets open. The company has had a tumultuous year, missing market revenue expectations in the previous three quarters. Additionally, the spotlight on its pending merger with Walgreens, still awaiting regulatory approval, has significantly impacted its stock, which is trading more than 50% lower than last year.
In the upcoming results for the quarter ended February, the markets expect Rite Aid to post $8.39 billion in revenues, which would imply a moderate growth of 1.5% over the prior year quarter. For the full year, the company is expected to post revenues of $32.8 billion, which would imply growth of 8% over the prior year. On the EPS front, the company is expected to report EPS of 6 cents, a decline of 1 cent over the prior year quarter.
- Rite Aid Stock Could Move Higher From $10
- Key Takeaways and Trends From Rite Aid’s Q2 FY’19 Earnings
- How Has Rite Aid Performed In FY 2018?
- What Are The Chances Of Rite Aid’s Recovery From Its Current Slump?
- Why Is Rite Aid’s Stock Performing So Poorly?
- Walgreens And Rite Aid Deal Is Back On Track And Both The Companies Are Expected To Gain
For the quarter ending February, we expect revenues of EnvisionRx, the acquisition which marked Rite Aid’s entry in the Pharmacy Benefit Management market, to increase over the prior year period and boost the company’s top line. Moreover, the holiday season is likely to positively impact the company’s retail revenues, which showed a decline in the past two quarters.
Owing to the pending regulatory approval of its merger with Walgreens, the company is not expected to hold an earnings call following the release of its quarterly results.
View Interactive Institutional Research (Powered by Trefis):
Global Large Cap | U.S. Mid & Small Cap | European Large & Mid Cap